alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

PROPOSED FINDINGS OF FACT AND 

DETERMINATION AS TO VIOLATIONS OF 

SUPERVISED RELEASE -1 

UNITED STATES DISTRICT COURT 

WESTERN DISTRICT OF WASHINGTON 

 AT SEATTLE 

 

UNITED STATES OF AMERICA, 

 Plaintiff, 

 v. 

SPENCER WYDELL WOODS, 

 Defendant. 

)

)

)

)

)

)

)

)

)

Case No. CR06-206- RSM 

PROPOSED FINDINGS OF FACT AND 

DETERMINATION AS TO ALLEGED 

VIOLATIONS OF SUPERVISED 

RELEASE

INTRODUCTION 

 I conducted a hearing on alleged violations of supervised release in this case on August 22, 

2008. The defendant appeared pursuant to a summons. The United States was represented by 

Sarah Vogel, and defendant was represented by Jeff Coopersmith. Also present was U.S. 

Probation Officer Brian Facklam. The proceedings were digitally recorded. 

CONVICTION AND SENTENCE 

Defendant was sentenced on October 27, 2006, for conspiracy to distribute cocaine and 

heroin. He received 20 months of imprisonment and three years of supervised release. 

PRESENTLY ALLEGED VIOLATION AND 

DEFENDANT'S ADMISSION OF THE VIOLATION 

In a petition dated April 9, 2008, Supervising U.S. Probation Officer Brian Facklam alleged 

that defendant violated the following condition of supervised release: 
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

PROPOSED FINDINGS OF FACT AND 

DETERMINATION AS TO VIOLATIONS OF 

SUPERVISED RELEASE -2 

 1. Committing the crimes of assault, second degree-domestic violence related (felony), 

unlawful imprisonment, and harassment in violation of the general condition that defendant 

commit no other Federal, State, or local crimes. 

In a petition dated August 13, 2008, Supervising U.S. Probation Officer Brian Facklam 

alleged that defendant violated the following condition of supervised release: 

2. Failing to abstain from the use of alcohol by using the substance in the month of February 

2008, in violation of the special condition requiring defendant to abstain from the use of alcohol. 

Defendant admitted violation 2, waived any hearing as to whether it occurred, and was 

informed that the matter would be set for a disposition hearing before District Judge Ricardo S. 

Martinez. The government has withdrawn violation 1. 

RECOMMENDED FINDINGS AND CONCLUSIONS 

Based upon the foregoing, I recommend the Court find that defendant has violated the 

conditions of his supervised release as alleged above, and conduct a disposition hearing. No 

request for detention was made and defendant remains in the community subject to all previously 

ordered conditions of supervision. 

 DATED this 21st day of August, 2008. 

A 

BRIAN A. TSUCHIDA 

United States Magistrate Judge
From: jkruzel1@comcast.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 6:38:45 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Joann Kruzel

Grand Rapids, MI 49504
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

 Although plaintiff asserts that two state court judges acted improperly, she has not

named them as defendants.

ORDER OF DISMISSAL - 1

UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF WASHINGTON

AT SEATTLE

LINDA L. FOGH, 

Plaintiff,

v.

WILLIAM JUSTYK,

Defendant.

Case No. C06-947RSL

ORDER OF DISMISSAL

This matter comes before the Court sua sponte. On July 7, 2006, the Court ordered

plaintiff to show cause why her complaint should not be dismissed for failing to show a basis for

this Court’s jurisdiction. Plaintiff filed a response on July 31, 2006.

As in her original filings, plaintiff continues to assert that this Court has jurisdiction

because she is seeking a writ of habeas corpus. As the Court explained in its order to show

cause, that allegation does not provide this Court with jurisdiction because plaintiff is not in

custody. Plaintiff also continues to allege violations of her constitutional rights, but does not

allege that the defendant is a state actor.1

 Plaintiff also did not respond to the Court’s statement

that although she attempts to invoke this Court’s admiralty jurisdiction, she has not shown any

basis for doing so. 

Case 2:06-cv-00947-RSL Document 10 Filed 08/17/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28 ORDER OF DISMISSAL - 2

For the foregoing reasons, the Court DISMISSES plaintiff’s complaint for lack of subject

matter jurisdiction.

DATED this 17th day of August, 2006.

A

Robert S. Lasnik

United States District Judge

Case 2:06-cv-00947-RSL Document 10 Filed 08/17/06 Page 2 of 2
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 1 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 2 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 3 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 4 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 5 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 6 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 7 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 8 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 9 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 10 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 11 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 12 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 13 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 14 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 15 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 16 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 17 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 18 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 19 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 20 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 21 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 22 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 23 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 24 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 25 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 26 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 27 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 28 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 29 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 30 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 31 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 32 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 33 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 34 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 35 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 36 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 37 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 38 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 39 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 40 of 41
Case 2:06-cv-00882-TSZ Document 3 Filed 06/21/06 Page 41 of 41
AMENDMENT
                                     to the
                 Employment Agreement executed November 9, 1999
                                     between
                 Dobson West and Eagle Pacific Industries, Inc.


         THIS AMENDMENT TO EMPLOYMENT AGREEMENT is entered into effective as of
this 15th day of December, 1999, by and between Dobson West (the "Employee") and
Eagle Pacific Industries, Inc. ("Eagle").


         WHEREAS, Employee and Eagle are parties to that certain Employment
Agreement executed November 9, 1999 (the "Agreement").

         WHEREAS, the parties mutually desire to amend the Agreement effective
December 15, 1999 to take into account the resolutions adopted by Eagle's Board
of Directors at its special meeting on December 15, 1999.

         NOW, THEREFORE, in consideration of the premises and mutual agreements
hereinafter contained, and for other good and valuable consideration, the
parties agree as follows:

         1. Section 3.b Bonus of the Agreement shall be changed in its entirety
to read as follows:

                  "During calendar year 1999, the Employee shall be entitled to
         participate in Level 1 of Eagle's Key Employee Bonus Plan, a summary of
         which is attached hereto as Exhibit A. Employee shall be eligible for a
         bonus under such plan for the year ending December 31, 1999 based on
         the compensation paid to Employee during such year. Beginning calendar
         year 2000 and for the remainder of the term of this Agreement, the
         Employee shall be entitled to participate in Eagle's Performance Bonus
         Plan."

         2. Except as amended herein, the Agreement shall remain in full force
and effect.

         IN WITNESS WHEREOF, the parties hereto have executed this Amendment to
Employment Agreement effective as of the date first written above.

EAGLE PACIFICS INDUSTRIES, INC.



By:  /s/ William H. Spell                    /s/ Dobson West
Its: Chief Executive Officer                 Dobson West
ORDER CONTINUING TRIAL DATE - 1

Judge Franklin D. Burgess

UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF WASHINGTON

AT TACOMA

UNITED STATES OF AMERICA, )

)

Plaintiff, ) NO. CR06-5267FDB

)

v. ) ORDER CONTINUING 

) TRIAL DATE 

GEORGE WILLIAMS, JR., )

)

Defendant. )

_____________________________________)

THIS MATTER comes before the Court pursuant to the stipulation of the parties to

continue the current trial date of October 16, 2006.

The defendant has indicated a willingness to cooperate not only with the government

of the Untied States, but also the State government in providing information that would be of

value to both governments. Additional time will be needed to evaluate the information the

defendant provides. There is insufficient time between now and the set trial date to

accomplish this. It is contemplated, with the continuing cooperation of the defendant, that

more than one meeting with him may be necessary. Assuming the continued cooperation

with the defendant and with the State and local authorities the sentence to be imposed on the

defendant in this matter maybe seriously affected. 

Case 3:06-cr-05267-BHS Document 25 Filed 10/05/06 Page 1 of 2
ORDER CONTINUING TRIAL DATE - 2

Having considered the entirety of the record, the files herein, and the representations

of the parties as set forth in their stipulation, this Court finds that the ends of justice are best

served in obtaining the cooperation of the defendant and outweigh the interests of the public

and the defendant in a speedy trial. 

IT IS NOW, THEREFORE, ORDERED that the trial date be continued from

October 16, 2006 to January 22, 2007. The period of delay resulting from this continuance

of the trial date from October 16, 2006, up to and including the new trial date of January

22, 2007 is hereby excluded under the Speedy Trial Act pursuant to Title 18, United States

Code, Sections 3161(h)(8)(A).

IT IS FURTHER ORDERED that the defendant shall file a waiver of his speedy trial

rights no later than October 5, 2006 to accommodate the requested continuance.

DATED this 5th day of October 2006. 

AFRANKLIN D. BURGESS

UNITED STATES DISTRICT JUDGE

Presented by:

________________________________

Anthony Savage, WSBA #2208

Attorney for Defendant

615 Second Avenue, Suite 340

Seattle, Washington 98104-2200

(206) 682-1882, fax (206) 682-1885

Email: loophole@integraonline.com

Case 3:06-cr-05267-BHS Document 25 Filed 10/05/06 Page 2 of 2
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 1 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 2 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 3 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 4 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 5 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 6 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 7 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 8 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 9 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 10 of 11
Case 2:06-cv-00697-RSL Document 219 Filed 09/08/09 Page 11 of 11
|What's New ·

What's Next ·

Site Map ·
A-Z Index ·
Careers ·

RSS ·
All Videos ·

Current FAQs |  | Search Advanced Search | 
|---------------------------------------------------------------------------------------------------------- |  | ---------------------- | 

Aboutthe Fed
    News& Events
    MonetaryPolicy
    BankingInformation& Regulation
    PaymentSystems
    EconomicResearch& Data
    Consumer Information
    CommunityDevelopment
    ReportingForms
    Publications


skip to content 
 Home Economic Research & Data Statistical Releases and Historical Data
 DDP Print
   Financial Accounts of the United States - Z.1 Current Release
Release Dates
Enhanced Financial Accounts
Financial Accounts Guide
Technical Q&As
Announcements
  L.229 Proprietors Equity in Noncorporate Business  
 Billions of dollars; amounts outstanding end of period, not seasonally adjusted Description
Series code
2014
2015
2015   Q1
2015   Q2
2015   Q3
2015   Q4
2016   Q1
2016   Q2
2016   Q3
LineHouseholds and nonprofit organizations; proprietors' equity in noncorporate business
	FL152090205
	10097.5
	10829.4
	10358.0
	10502.4
	10661.3
	10829.4
	10881.1
	11013.9
	11174.0
	1Nonfinancial noncorporate business; proprietors' equity in noncorporate business (net worth)
	FL112090205
	10079.6
	10814.8
	10340.4
	10485.6
	10643.8
	10814.8
	10869.9
	11003.3
	11159.7
	2Security brokers and dealers; proprietors' equity in noncorporate business
	FL662090205
	17.9
	14.7
	17.6
	16.8
	17.5
	14.7
	11.2
	10.7
	14.4
	3 Back to top
   Home Economic Research & Data
 Accessibility Contact Us Disclaimer Website Policies FOIA
 PDF Reader
9/21/2015 Search for FDA Guidance Documents > Acceptance of Foreign Clinical Studies ­ Information Sheet

http://www.fda.gov/RegulatoryInformation/Guidances/ucm126426.htm 1/2

Acceptance of Foreign Clinical Studies ­ Information Sheet

Guidance for Institutional Review Boards and Clinical Investigators

The Food and Drug Administration (FDA) may accept clinical studies conducted outside the United States in

support of safety and efficacy claims for drugs, biological products and medical devices.

All drug, biologic and device studies conducted under an Investigational New Drug (IND) or Investigational

Device Exemption (IDE) are governed by the FDA informed consent and IRB requirements. [See 21 CFR

part 312 IND regulations and 21 CFR part 812 IDE regulations.]

Under 21 CFR 312.120(c)(1), FDA will accept a foreign clinical study involving a drug or biological product

not conducted under an IND. On April 28, 2008, FDA issued a final rule modifying 21 CFR 312.120, entitled

Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug

Application. This final rule and its preamble are available at

http://www.regulations.gov/#!documentDetail;D=FDA­2004­N­0061­0002;oldLink=false

1.

Under 21 CFR 814.15(a) and (b), FDA will accept a foreign clinical study involving a medical device not

conducted under an IDE only if the study conforms to whichever of the following provides greater

protection of the human subjects:

the ethical principles contained in the 1983 version of the Declaration of Helsinki, or

the laws and regulations of the country in which the research was conducted.

Also see these FDA Information Sheets:

Non­Local IRB Review2

Waiver of IRB Requirements for Drug and Biologic Studies

3

Guide to Informed Consent

4

Page Last Updated: 06/25/2014

Note: If you need help accessing information in different file formats, see Instructions for Downloading

Viewers and Players.

Accessibility Contact FDA Careers FDA Basics FOIA No FEAR Act Site Map Transparency Website

Policies

U.S. Food and Drug Administration

10903 New Hampshire Avenue

Silver Spring, MD 20993

Ph. 1­888­INFO­FDA (1­888­463­6332)

Contact FDA

For Government For Press

Combination Products Advisory Committees Science & Research Regulatory Information Safety

Emergency Preparedness International Programs News & Events Training and Continuing Education

Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive

Regulatory Information

Home Regulatory Information Search for FDA Guidance Documents
9/21/2015 Search for FDA Guidance Documents > Acceptance of Foreign Clinical Studies ­ Information Sheet

http://www.fda.gov/RegulatoryInformation/Guidances/ucm126426.htm 2/2

Links on this page:

1. http://www.regulations.gov/#!documentDetail;D=FDA­2004­N­0061­

0002;oldLink=false

2. /RegulatoryInformation/Guidances/ucm126423.htm

3. /downloads/RegulatoryInformation/Guidances/UCM126500.pdf

4. /RegulatoryInformation/Guidances/ucm126431.htm
III

105TH CONGRESS

2D SESSION S. RES. 198

Designating April 1, 1998, as ‘‘National Breast Cancer Survivors’ Day’’.

IN THE SENATE OF THE UNITED STATES

MARCH 18, 1998

Mr. MACK (for himself, Mrs. FEINSTEIN, Mr. LOTT, Mr. DASCHLE, Mr.

HATCH, Mr. LEAHY, Mr. ABRAHAM, Mr. AKAKA, Mr. ALLARD, Mr. BAUCUS, Mr. BENNETT, Mr. BIDEN, Mr. BOND, Mrs. BOXER, Mr. BREAUX,

Mr. BROWNBACK, Mr. BRYAN, Mr. CAMPBELL, Mr. CHAFEE, Mr.

CLELAND, Mr. COCHRAN, Ms. COLLINS, Mr. COVERDELL, Mr. CRAIG,

Mr. D’AMATO, Mr. DEWINE, Mr. DODD, Mr. DOMENICI, Mr. DORGAN,

Mr. DURBIN, Mr. ENZI, Mr. FAIRCLOTH, Mr. FORD, Mr. FRIST, Mr.

GLENN, Mr. GORTON, Mr. GRAMM, Mr. GRASSLEY, Mr. GREGG, Mr.

HAGEL, Mrs. HUTCHISON, Mr. KOHL, Mr. INHOFE, Mr. INOUYE, Mr.

JEFFORDS, Mr. JOHNSON, Mr. KENNEDY, Mr. KERREY, Ms. LANDRIEU,

Mr. LAUTENBERG, Mr. LEVIN, Mr. LIEBERMAN, Mr. LUGAR, Mr.

MCCONNELL, Ms. MIKULSKI, Mr. MOYNIHAN, Ms. MOSELEY-BRAUN, Mr.

MURKOWSKI, Mrs. MURRAY, Mr. NICKLES, Mr. REED, Mr. REID, Mr.

ROBB, Mr. ROCKEFELLER, Mr. SARBANES, Mr. SESSIONS, Mr. SMITH of

New Hampshire, Mr. SMITH of Oregon, Ms. SNOWE, Mr. SPECTER, Mr.

STEVENS, Mr. THOMAS, Mr. TORRICELLI, Mr. WARNER, Mr.

WELLSTONE, and Mr. COATS) submitted the following resolution; which

was referred to the Committee on the Judiciary

RESOLUTION

Designating April 1, 1998, as ‘‘National Breast Cancer

Survivors’ Day’’.

Whereas breast cancer strikes an estimated 178,700 women

and 1,600 men in the United States annually;
2

•SRES 198 IS

Whereas breast cancer strikes 1 out of every 9 American

women during an average woman’s lifetime;

Whereas breast cancer is the leading cause of death among

American women between the ages of 35 and 54;

Whereas during this decade, it is estimated that more than

1,800,000 women and 12,000 men will be diagnosed with

breast cancer in the United States;

Whereas when breast cancer is detected at an early stage, the

5 year survival rate is 97 percent;

Whereas according to the United States Centers for Disease

Control and Prevention, the percentage of American

women who die from breast cancer has begun to decline;

Whereas according to the United States Centers for Disease

Control and Prevention, the mortality rate among American women with breast cancer decreased during the period from 1990 to 1995; and

Whereas breast cancer survivors have shown tremendous

courage and determination in the face of adversity: Now,

therefore, be it

1 Resolved, That the Senate—

2 (1) designates April 1, 1998, as ‘‘National

3 Breast Cancer Survivors’ Day’’; and

4 (2) requests the President to issue a proclama5 tion calling upon the people of the United States to

6 observe the day with appropriate programs and ac7 tivities.

Æ